mind & bodyScienceDaily

Common osteoporosis drugs linked to 24% lower dementia risk in major study

from ScienceDaily

A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s disease and other dementias by up to 24%. The surprising findings raise the possibility that medications already used to strengthen bones could also help protect the aging brain.

explained

Bisphosphonates are a class of drugs that prevent the loss of bone density. They are the most commonly prescribed to treat osteoporosis and similar diseases.

Specifically, there is evidence that shows they may reduce the risk of fracture in post-menopausal women with osteoporosis.

Bone tissue undergoes constant remodeling and is kept in balance (homeostasis) by osteoblasts creating bone and osteoclasts destroying bone. Bisphosphonates inhibit the digestion of bone by encouraging osteoclasts to undergo apoptosis, or cell death, thereby slowing bone loss.

The uses of bisphosphonates include the prevention and treatment of osteoporosis, Paget's disease of bone, bone metastasis (with or without hypercalcemia), multiple myeloma, primary hyperparathyroidism, osteogenesis imperfecta, fibrous dysplasia, and other conditions that exhibit bone fragility.

From Wikipedia: Bisphosphonate (CC BY-SA 4.0) ↗
so what

If confirmed, a familiar and inexpensive drug class could offer a new route to protecting against dementia. The link still needs controlled trials before it can guide treatment.

more on this

Illustrative photo · James Heilman, MD, CC BY-SA 3.0, via Wikimedia Commons